Indian experience of lenvatinib in radio-iodine refractory differentiated thyroid cancer
| العنوان: | Indian experience of lenvatinib in radio-iodine refractory differentiated thyroid cancer |
|---|---|
| المؤلفون: | Shekar Patil, Shashidhara H P, Ravi Thippeswamy, Kumarswamy Gangadharaiah Kallur, Satheesh Chiradoni Thungappa |
| المصدر: | Journal of Clinical Oncology. 36:e18107-e18107 |
| بيانات النشر: | American Society of Clinical Oncology (ASCO), 2018. |
| سنة النشر: | 2018 |
| مصطلحات موضوعية: | Oncology, endocrine system, Cancer Research, medicine.medical_specialty, endocrine system diseases, medicine.medical_treatment, Thyroid carcinoma, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Refractory, hemic and lymphatic diseases, Internal medicine, medicine, 030223 otorhinolaryngology, Thyroid cancer, Chemotherapy, Radio iodine, business.industry, medicine.disease, chemistry, 030220 oncology & carcinogenesis, Radioactive iodine, Lenvatinib, business |
| الوصف: | e18107Background: Differentiated thyroid cancer (DTC) accounts for approximately 95% of thyroid carcinomas. Chemotherapy has very limited efficacy in metastatic Radioactive Iodine (RAI)-refractory ... |
| تدمد: | 1527-7755 0732-183X |
| DOI: | 10.1200/jco.2018.36.15_suppl.e18107 |
| URL الوصول: | https://explore.openaire.eu/search/publication?articleId=doi_________::518fc9f9463e6d811495701a3475e870 https://doi.org/10.1200/jco.2018.36.15_suppl.e18107 |
| رقم الانضمام: | edsair.doi...........518fc9f9463e6d811495701a3475e870 |
| قاعدة البيانات: | OpenAIRE |
| تدمد: | 15277755 0732183X |
|---|---|
| DOI: | 10.1200/jco.2018.36.15_suppl.e18107 |